A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

Last updated:
2026-07-25
Language and content disclaimer

The content and search results on this site are collected from or provided by third parties. As such some of the information may only be available in the language originally submitted by the sponsor of the trial. Learn more about the information on the search portal.

Linking to Non-Government of Canada Websites

Links to websites not under the control of the Government of Canada, including those to our social media accounts, and to clinical trial records in international registries are provided solely for the convenience of our website visitors. We are not responsible for the accuracy, currency or reliability of the content of such websites. The Government of Canada does not offer any guarantee in that regard and is not responsible for the information found through these links, nor does it endorse the sites and their content.

Visitors should also be aware that information offered by non-Government of Canada sites to which this website links is not subject to the Privacy Act or the Official Languages Act and may not be accessible to persons with disabilities. The information offered may be available only in the language(s) used by the sites in question. With respect to privacy, visitors should research the privacy policies of these non-government websites before providing personal information.

View trial details

Overview

Official protocol title:

A DOSE-FINDING, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF GSK4532990 FOR STEATOHEPATITIS IN ADULTS WITH ALCOHOL RELATED LIVER DISEASE (ALD)

Intervention/treatment:
GSK4532990
Medical condition:
LIVER DISEASE
Protocol code:
222291
Control number:
290974
Status:
Recruiting
Approved:
October 29, 2024
Trial phase:
Phase 2
For more information:
ClinicalTrials.gov - NCT06613698
This is an external link. The information is not authorized by the Government of Canada.

Eligibility

Sex: ALL
Age
18 Years to 70 Years
Accepts healthy volunteers: No

Contacts and locations

Contact
Name
US GSK Clinical Trials Call Center
Role
CONTACT
Phone:
877-379-3718
Name
EU GSK Clinical Trials Call Center
Role
CONTACT
Phone:
+44 (0) 20 89904466
Sponsor
GLAXOSMITHKLINE INC

Locations

Alberta

GSK Investigational Site
Calgary, Alberta, T2N 4Z6
RECRUITING
Name
US GSK Clinical Trials Call Center
Role
CONTACT
Phone:
877-379-3718
Name
EU GSK Clinical Trials Call Centre
Role
CONTACT
Phone:
+44 (0) 20 8990 4466
Name
Henry Nguyen
Role
PRINCIPAL_INVESTIGATOR

British Columbia

GSK Investigational Site
New Westminster, British Columbia, V3L 3W4
RECRUITING
Name
US GSK Clinical Trials Call Center
Role
CONTACT
Phone:
877-379-3718
Name
EU GSK Clinical Trials Call Centre
Role
CONTACT
Phone:
+44 (0) 20 8990 4466
Name
Steven Cheuk-Fung Pi
Role
PRINCIPAL_INVESTIGATOR
GSK Investigational Site
Vancouver, British Columbia, V6Z 2K5
RECRUITING
Name
US GSK Clinical Trials Call Center
Role
CONTACT
Phone:
877-379-3718
Name
EU GSK Clinical Trials Call Centre
Role
CONTACT
Phone:
+44 (0) 20 8990 4466
Name
Alnoor Ramji
Role
PRINCIPAL_INVESTIGATOR

Ontario

GSK Investigational Site
London, Ontario, N6A 5A5
RECRUITING
Name
US GSK Clinical Trials Call Center
Role
CONTACT
Phone:
877-379-3718
Name
EU GSK Clinical Trials Call Centre
Role
CONTACT
Phone:
+44 (0) 20 8990 4466
Name
Mohammad Qasim Khan
Role
PRINCIPAL_INVESTIGATOR
GSK Investigational Site
Toronto, Ontario, M1S 4T7
RECRUITING
Name
US GSK Clinical Trials Call Center
Role
CONTACT
Phone:
877-379-3718
Name
EU GSK Clinical Trials Call Centre
Role
CONTACT
Phone:
+44 (0) 20 8990 4466
Name
Gerald Chan
Role
PRINCIPAL_INVESTIGATOR
GSK Investigational Site
Toronto, Ontario, M5G 2C4
RECRUITING
Name
US GSK Clinical Trials Call Center
Role
CONTACT
Phone:
877-379-3718
Name
EU GSK Clinical Trials Call Centre
Role
CONTACT
Phone:
+44 (0) 20 8990 4466
Name
Jordan Feld
Role
PRINCIPAL_INVESTIGATOR

Quebec

GSK Investigational Site
Montreal, Quebec, H2X 0A9
RECRUITING
Name
US GSK Clinical Trials Call Center
Role
CONTACT
Phone:
877-379-3718
Name
EU GSK Clinical Trials Call Centre
Role
CONTACT
Phone:
+44 (0) 20 8990 4466
Name
Julian Hercun
Role
PRINCIPAL_INVESTIGATOR
GSK Investigational Site
Terrebonne, Quebec, J6X 4P7
RECRUITING
Name
US GSK Clinical Trials Call Center
Role
CONTACT
Phone:
877-379-3718
Name
EU GSK Clinical Trials Call Centre
Role
CONTACT
Phone:
+44 (0) 20 8990 4466
Name
Yves Robitaille
Role
PRINCIPAL_INVESTIGATOR
Did you find what you were looking for?

Contacts and resources